T

Tarsus Pharmaceuticals
D

TARS

48.215
USD
1.78
(3.82%)
مغلق
حجم التداول
0
الربح لكل سهم
-3
العائد الربحي
-
P/E
-13
حجم السوق
1,843,111,382
الأخبار

العنوان: Tarsus Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.